MKD Pharmaceuticals Private Limited
About MKD Pharmaceuticals Private Limited
Data last updated:
MKD Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 03 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PTC352122. Its GSTIN is 10AAMCM7844B1ZP (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munishwar Dwivedi and Mundrika Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 20 Kh.No.264/228/173 Ground Floor Gali No – 2 Village Wazirabad Extn, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.04 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹2,892 (net margin -2.8%) and EBITDA of -₹2,892 (EBITDA margin -2.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No 20 Kh.No.264/228/173 Ground Floor Gali No – 2 Village Wazirabad Extn, Delhi, India – 110084
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of MKD Pharmaceuticals Private Limited
The main business activity of MKD Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MKD Pharmaceuticals Private Limited FY 2025 filings available
MKD Pharmaceuticals Private Limited reported revenue of ₹1.04 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of MKD Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 1% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MKD Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2,892 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2,892 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MKD Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MKD Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Olimeds Pharmaceuticals Private Limited | ₹1.08 Lakh (FY 2025) | •••• | •••• | 365.0% | •••• | Jaipur, Rajasthan, India |
| Gynokem Pharmaceuticals Private Limited | ₹1.06 Lakh (FY 2021) | •••• | •••• | •••• | Indore, Madhya Pradesh, India | |
| Rejubone Pharmaceuticals Private Limited | ₹1.06 Lakh (FY 2022) | •••• | •••• | -54.0% | •••• | Delhi, India |
| Kendula Pharmaceuticals Private Limited | ₹1.05 Lakh (FY 2025) | •••• | •••• | •••• | Patna, Bihar, India | |
| Glanstar Pharmaceuticals Private Limited | ₹1.05 Lakh (FY 2024) | •••• | •••• | 317.0% | •••• | Akbarpur, Uttar Pradesh, India |
| MKD Pharmaceuticals Private Limited this company | ₹1.04 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Delhi, India |
| Mabkin Pharmaceuticals Private Limited | ₹1.04 Lakh (FY 2024) | •••• | •••• | -85.0% | •••• | Mumbai, Maharashtra, India |
| Medinode Pharmaceuticals Private Limited | ₹1.04 Lakh (FY 2025) | •••• | •••• | -55.0% | •••• | Aligarh, Uttar Pradesh, India |
| Green Quick Pharmaceuticals Private Limited | ₹1.01 Lakh (FY 2024) | •••• | •••• | 276.0% | •••• | Delhi, India |
| Aikvira Pharmaceuticals Private Limited | ₹1 Lakh (FY 2025) | •••• | •••• | 230.0% | •••• | Thane, Maharashtra, India |
| Nazwin Pharmaceuticals Private Limited | ₹1 Lakh (FY 2019) | •••• | •••• | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below MKD Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munishwar Dwivedi | Director | 03 Jul 2019 | 7 Years 3 Months | Current |
| Mundrika Devi | Director | 03 Jul 2019 | 7 Years 3 Months | Current |
Ownership and Shareholding of MKD Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at MKD Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to MKD Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mundrika Devi was appointed as Director on 03 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for MKD Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MKD Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MKD Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAMCM7844B1ZP | Bihar | Active | 01 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MKD Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MKD Pharmaceuticals Private Limited
MKD Pharmaceuticals is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 03 July 2019 (7+ years old) and is registered under CIN U24299DL2019PTC352122.
MKD Pharmaceuticals reported revenue of ₹1.04 Lakh for FY 2025 (up 1% YoY).
MKD Pharmaceuticals has 2 current directors:
- Munishwar Dwivedi - Director
- Mundrika Devi - Director
MKD Pharmaceuticals reported a net loss of ₹2,892 (net margin -2.8%) and EBITDA of -₹2,892 (EBITDA margin -2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MKD Pharmaceuticals is 18% over five years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MKD Pharmaceuticals is 10AAMCM7844B1ZP, registered in Bihar.
The CIN (Corporate Identification Number) of MKD Pharmaceuticals is U24299DL2019PTC352122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MKD Pharmaceuticals was incorporated on 03 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of MKD Pharmaceuticals by revenue are Olimeds Pharmaceuticals Private Limited, Gynokem Pharmaceuticals Private Limited, Rejubone Pharmaceuticals Private Limited, Kendula Pharmaceuticals Private Limited, Glanstar Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mundrika Devi was appointed as Director on 03 Jul 2019. Munishwar Dwivedi was appointed as Director on 03 Jul 2019.
The registered office of MKD Pharmaceuticals is at House No 20 Kh.No.264228173 Ground Floor Gali No – 2 Village Wazirabad Extn, Delhi, India – 110084.